Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade

Background Oncolytic viruses (OVs) are capable to inflame the tumor microenvironment (TME) and elicit infiltrating tumor-specific T cell responses. However, OV treatment negatively alters the cancer-immune set point in tumors to attenuate the antitumor immune response, which suggests the necessity o...

全面介紹

書目詳細資料

Principais autores:	Jun Zhang, Min Zhao, Ningshao Xia, Yong Luo, Fei Ju, Chaolong Lin, Xian Jia, Zilong Xu, Rui Tian, Yanhua Lin, Yating Chang, Xiaoxuan Huang, Shaopeng Li, Wenfeng Ren, Yaning Qin, Mengqin Yu, Jizong Jia, Jinle Han, Wenxin Luo, Guo Fu, Xiangzhong Ye, Chenghao Huang
格式:	Artigo
語言:	Inglês
出版:	BMJ Publishing Group 2022-06-01
叢編:	Journal for ImmunoTherapy of Cancer
在線閱讀:	https://jitc.bmj.com/content/10/6/e004762.full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!